Treatment of active rheumatoid arthritis: comparison of patients younger vs older than 75 years (CORPUS cohort) - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Human Vaccines and Immunotherapeutics Année : 2018

Treatment of active rheumatoid arthritis: comparison of patients younger vs older than 75 years (CORPUS cohort)

Résumé

Objectives: Little information is available on the characteristics of elderly patients starting TNFalpha antagonist treatment for rheumatoid arthritis (RA). The objective of this work was to compare prescription patterns in RA patients younger vs. older than 75 years. Methods: Biologic-naive patients with active RA (DAS28 > 3.2) despite first-line therapy were included between 2007 and 2009 in the prospective, multicentre, longitudinal, observational, population-based CORPUS-RA cohort. TNFalpha antagonist users were defined as having received at least one TNFalpha antagonist during the first study year. The groups < 75 years and >/= 75 years were compared regarding comorbidities, inflammation (CRP and ESR), disease activity (DAS28), disability (HAQ-DI), number of physician visits, and treatment. To verify the impact of the cut off, we also compared patients aged 70 years or more to patients younger than 70 years. Results: Of 543 RA patients, 382 had complete one-year follow-up data, including 114 TNFalpha antagonist users, 3 (6%) among the 49 patients aged 75 years or over and 111 (32%) of the 333 patients younger than 75 years (p < 0.01). Disease activity in the two age groups was similar at inclusion and after one year. Comorbidities and a history of auto-immunity were more common in the older group. Compared to their younger counterparts, the older patients received glucocorticoids more often (p = 0.003) and synthetic disease-modifying anti-rheumatic drugs less often (p = 0.01). Conclusion: TNFalpha antagonists are used less often and glucocorticoids more often in elderly patients with active RA compared to their younger counterparts. The fact that this study was performed in 2007-9 is a limitation in terms of relevance to today's patients and further studies should be conducted in new cohorts of active RA.

Domaines

Immunologie
Fichier principal
Vignette du fichier
islandora_137442.pdf (1.06 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03949919 , version 1 (20-01-2023)

Identifiants

Citer

Sachiyo Oishi, Daniel Wendling, Jean Sibilia, Chantal Job-Deslandre, Loic Guillevin, et al.. Treatment of active rheumatoid arthritis: comparison of patients younger vs older than 75 years (CORPUS cohort). Human Vaccines and Immunotherapeutics, 2018, 14 (11), pp.2612-2617. ⟨10.1080/21645515.2018.1522470⟩. ⟨hal-03949919⟩
12 Consultations
6 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More